Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Atara Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- −14 vs. Q4 2022
- Shares held
- 102.7M
- +5.35M (+5.5%) vs. Q4 2022
- Total value
- $297.8M
- −$21.5M (−6.7%) vs. Q4 2022
- New holders
- 8
- 52 more added
- Sold out
- 22
- 42 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $51.3M |
| Q1 2026 | 33 | $12.1M |
| Q4 2025 | 41 | $37.1M |
| Q3 2025 | 37 | $27.0M |
| Q2 2025 | 32 | $13.9M |
| Q1 2025 | 37 | $12.4M |
| Q4 2024 | 43 | $31.5M |
| Q3 2024 | 35 | $19.6M |
| Q2 2024 | 48 | $24.1M |
| Q1 2024 | 82 | $57.8M |
| Q4 2023 | 91 | $33.2M |
| Q3 2023 | 109 | $130.5M |
| Q2 2023 | 118 | $145.8M |
| Q1 2023 | 125 | $297.8M |
| Q4 2022 | 139 | $319.3M |
| Q3 2022 | 155 | $376.2M |
| Q2 2022 | 134 | $777.4M |
| Q1 2022 | 145 | $909.5M |
| Q4 2021 | 139 | $1.50B |
| Q3 2021 | 140 | $1.61B |
| Q2 2021 | 145 | $1.34B |
| Q1 2021 | 151 | $1.24B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Atara Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rafferty Asset Management, LLC | 710,258 | $2.06M | 0.01% | +60,480+9.3% | Added |
| Baker Bros. Advisors LP | 744,186 | $2.16M | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 876,864 | $2.54M | 0.00% | −4,038−0.5% | Reduced |
| Citigroup Inc | 911,219 | $2.64M | 0.00% | −114,199−11.1% | Reduced |
| Antipodean Advisors LLC | 1,000,000 | $2.90M | 17.94% | 00.0% | Unchanged |
| Bank of America Corp | 1,214,300 | $3.52M | 0.00% | +837,836+222.6% | Added |
| Norges Bank | 1,216,213 | $3.53M | 0.00% | +347,555+40.0% | Added |
| Dimensional Fund Advisors LP | 1,432,142 | $4.15M | 0.00% | +543,977+61.2% | Added |
| Renaissance Technologies LLC | 1,437,700 | $4.17M | 0.01% | +1,272,700+771.3% | Added |
| Ameriprise Financial Inc | 1,479,865 | $4.29M | 0.00% | +146,445+11.0% | Added |
| Nuveen Asset Management, LLC | 1,662,112 | $4.82M | 0.00% | +387,265+30.4% | Added |
| Geode Capital Management, LLC | 1,914,578 | $5.55M | 0.00% | +70,960+3.8% | Added |
| Citadel Advisors LLC | 2,251,718 | $6.53M | 0.01% | +853,953+61.1% | Added |
| Morgan Stanley | 2,947,236 | $8.55M | 0.00% | +257,492+9.6% | Added |
| D. E. Shaw & Co., Inc. | 4,229,807 | $12.3M | 0.02% | +697,807+19.8% | Added |
| Redmile Group, LLC | 5,612,056 | $16.3M | 0.71% | −630,700−10.1% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 6,290,713 | $18.2M | 0.47% | −3000.0% | Reduced |
| Goldman Sachs Group Inc | 6,671,703 | $19.3M | 0.01% | +428,090+6.9% | Added |
| Vanguard Group Inc | 6,855,186 | $19.9M | 0.00% | −355,862−4.9% | Reduced |
| JPMorgan Chase & Co | 7,655,769 | $22.2M | 0.00% | +156,334+2.1% | Added |
| State Street Corp | 8,237,473 | $23.9M | 0.00% | +587,733+7.7% | Added |
| Wasatch Advisors Inc | 8,354,321 | $24.2M | 0.15% | −36,693−0.4% | Reduced |
| Baupost Group LLCSuperinvestorBaupost Group | 9,123,616 | $26.5M | 0.45% | +1,000,000+12.3% | Added |
| BlackRock Inc. | 9,271,298 | $26.9M | 0.00% | +119,149+1.3% | Added |
| IFP Advisors, Inc | 2,400 | – | – | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −601,005−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −462,308−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −208,100−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −183,283−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −92,629−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −65,659−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −55,997−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −44,751−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −35,475−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −34,728−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −28,652−100.0% | Sold out |
| Globeflex Capital L P | 0 | $0 | 0.00% | −25,783−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −18,819−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −8,300−100.0% | Sold out |
| Hall Laurie J Trustee | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −15−100.0% | Sold out |